Uncategorized

After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry – statnews.com

Posted on Author Tim Hodges Comments Off on After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry – statnews.com
  1. After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry  statnews.com
  2. Second patient death reported with gene therapy for muscular dystrophy  AP News
  3. Roche Pauses Commercial and Clinical Use of Elevidys After Fatal Liver Failures  WSJ
  4. Sarepta Therapeutics Stock Plunges as Second Patient Dies Taking Its Drug  Investopedia
  5. Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne  Business Wire